Desmoid tumors develop from connective tissue, fasciae, and aponeuroses, and may occur in the context of familial adenomatous polyposis or may arise sporadically; also, they may be extra-abdominal, intra-abdominal, or located in the abdominal wall. These benign tumors have a great aggressiveness with a high rate of local recurrence. Familial adenomatous polyposis is an inherited condition with autosomal dominant transmission, and is characterized by the development of multiple colonic and rectal adenomatous polyps, as well as desmoid tumors. We present the case of a 54-year-old woman with germline APC gene mutation, who underwent a total colectomy, subsequently developing two large infiltrative solid intra-abdominal lesions consistent with desmoid tumors. Medical treatment with Cox-2 inhibitors was initiated without result. She was submitted to resection for intestinal obstruction, but developed local recurrence. The lesions were also unresponsive to tamoxifen, and chemotherapy was initiated with dacarbazine plus doxorubicin, switching to vinorelbine plus methotrexate, achieving a good response in all lesions after 12 months. The approach to these intra-abdominal lesions should be progressive, beginning with observation, then a medical approach with non-steroidal anti-inflammatory drugs or with an anti-hormonal agent. Afterwards, if progression is still evident, chemotherapy should be started. Surgery should be reserved for resistance to medical treatment, in palliative situations, or for extra-abdominal or abdominal wall desmoids tumors.
Keywords
Fibromatosis, Aggressive, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Drug Therapy
References
TanakaK, ToiyamaY, OkugawaY, et al. Cytoreductive strategy for multiple intra-abdominal and abdominal wall desmoid tumors in familial adenomatous polyposis: report of three cases. Clin J Gastroenterol. 2012;5(5):361-6. [https://doi.org/10.1007/s12328-012-0330-5]. [PMID:26181076]
ColomboC, FooWC, WhitingD, et al. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol. 2012;27(5):641-9. [PMID:22419028]
FioreM, RimareixF, MarianiL, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16(9):2587-93. [https://doi.org/10.1245/s10434-009-0586-2]. [PMID:19568815]
LatchfordAR, SturtNJ, NealeK, RogersPA, PhillipsRK. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg. 2006;93(10):1258-64. [https://doi.org/10.1002/bjs.5425]. [PMID:16952208]
VitellaroM, SalaP, SignoroniS, et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg. 2014;101(5):558-65. [https://doi.org/10.1002/bjs.9411]. [PMID:24493089]
SturtNJ, GallagherMC, BassettP, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut. 2004;53(12):1832-6. [https://doi.org/10.1136/gut.2004.042705]. [PMID:15542524]
BasdanisG, PapadopoulosVN, PanidisS, et al. Desmoid tumor of mesentery in familial adenomatous polyposis: a case report. Tech Coloproctol. 2010;14(Suppl 1):S61-2. [https://doi.org/10.1007/s10151-010-0613-0]. [PMID:20683751]
NieuwenhuisMH, Mathus-VliegenEM, BaetenCG, et al. Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer. 2011;104(1):37-42. [https://doi.org/10.1038/sj.bjc.6605997]. [PMID:21063417]
MartinsS, LeiteJ, OliveiraA, et al. Tratamento dos tumores desmoides intra-abdominais associados à Polipose Adenomatosa Familiar. Rev Port Cir. 2015;32:17-25.
JungWB, KimCW, KimJC. Clinical characteristics adequate treatment of familial adenomatous polyposis combined with desmoid tumors. Cancer Res Treat. 2014;46(4):366-73. [https://doi.org/10.4143/crt.2013.185]. [PMID:25152189]
TurinaM, PavlikCM, HeinimannK, BehrensmeierF, SimmenHP. Recurrent desmoids determine outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-positive family across 30 years. Int J Colorectal Dis. 2013;28(6):865-72. [https://doi.org/10.1007/s00384-012-1600-x]. [PMID:23114473]
ToiyamaY, KonishiN, InoueY, et al. Successful treatment of ileal pouch desmoids using multimodal chemotherapy with low-dose vinblastine and methotrexate in a patient with familial adenomatous polyposis. Clin J Gastroenterol. 2009;2(3):170-4. [https://doi.org/10.1007/s12328-008-0055-7]. [PMID:26192289]
YamamotoH, OshiroR, NishimuraJ, et al. Low-dose dacarbazine-doxorubicin therapy against intra-abdominal desmoid tumors. Oncol Rep. 2013;29(5):1751-5. [https://doi.org/10.3892/or.2013.2345]. [PMID:23503528]
GegaM, YanagiH, YoshikawaR, et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol. 2006;24(1):102-5. [https://doi.org/10.1200/JCO.2005.02.1923]. [PMID:16382119]
ChughR, WathenJK, PatelSR, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res. 2010;16(19):4884-91. [https://doi.org/10.1158/1078-0432.CCR-10-1177]. [PMID:20724445]
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email